Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation
- Status
- UNKNOWN
- Phase
- NA
Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients
- Status
- COMPLETED
- Phase
- PHASE4
Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
- Status
- UNKNOWN
- Phase
- NA
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection
- Status
- COMPLETED
- Phase
- NA
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- NA
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study in Asia of the Combination of TACE With Sorafenib in HCC Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Pegylated Human Recombinant Arginase for Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE1